Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Physio-Control Lifepak 11 defibrillator/pacer 510(k) pending at FDA -- IPO prospectus.

This article was originally published in The Gray Sheet

Executive Summary

PHYSIO-CONTROL LIFEPAK 11 DEFIBRILLATOR/PACEMAKER 510(K) PENDING at FDA, the company says in a preliminary prospectus for an initial public offering. The advanced life support system, designed for use with Physio-Control's Lifepak 11 vital signs monitor, "provides for defibrillation and pacing together with 12-lead diagnostic assessment capabilities to diagnose myocardial infarction in the out-of-hospital environment," according to the company.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts